問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberAC220-A-U302
Completed

2016-08-01 - 2024-03-31

Phase III

Terminated6

  • Sponsor

  • Trial scale

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Po-Shen Ko

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tung-Liang Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tsai-Yun Chen

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator - -

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Su-Peng Yeh

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    29 participants

  • Global

    539 participants